Global Commercializing Biomarkers Market Professional Survey Report 2017


Report ID : RNR-76590 Category : Biotechnology Published Date : May 2017
Publisher : S&P Consulting Pages : 117 Format : PDF
This report studies Commercializing Biomarkers in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI

By types, the market can be split into
Consumables
Services
Software

By Application, the market can be split into
Oncology
Cardiology
Neurology
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents

Global Commercializing Biomarkers Market Professional Survey Report 2017
1 Industry Overview of Commercializing Biomarkers
1.1 Definition and Specifications of Commercializing Biomarkers
1.1.1 Definition of Commercializing Biomarkers
1.1.2 Specifications of Commercializing Biomarkers
1.2 Classification of Commercializing Biomarkers
1.2.1 Consumables
1.2.2 Services
1.2.3 Software
1.3 Applications of Commercializing Biomarkers
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Neurology
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers
2.3 Manufacturing Process Analysis of Commercializing Biomarkers
2.4 Industry Chain Structure of Commercializing Biomarkers

3 Technical Data and Manufacturing Plants Analysis of Commercializing Biomarkers
3.1 Capacity and Commercial Production Date of Global Commercializing Biomarkers Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Commercializing Biomarkers Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Commercializing Biomarkers Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Commercializing Biomarkers Major Manufacturers in 2016

4 Global Commercializing Biomarkers Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Commercializing Biomarkers Capacity and Growth Rate Analysis
4.2.2 2016 Commercializing Biomarkers Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Commercializing Biomarkers Sales and Growth Rate Analysis
4.3.2 2016 Commercializing Biomarkers Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Commercializing Biomarkers Sales Price
4.4.2 2016 Commercializing Biomarkers Sales Price Analysis (Company Segment)

5 Commercializing Biomarkers Regional Market Analysis
5.1 North America Commercializing Biomarkers Market Analysis
5.1.1 North America Commercializing Biomarkers Market Overview
5.1.2 North America 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Commercializing Biomarkers Sales Price Analysis
5.1.4 North America 2016 Commercializing Biomarkers Market Share Analysis
5.2 China Commercializing Biomarkers Market Analysis
5.2.1 China Commercializing Biomarkers Market Overview
5.2.2 China 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Commercializing Biomarkers Sales Price Analysis
5.2.4 China 2016 Commercializing Biomarkers Market Share Analysis
5.3 Europe Commercializing Biomarkers Market Analysis
5.3.1 Europe Commercializing Biomarkers Market Overview
5.3.2 Europe 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Commercializing Biomarkers Sales Price Analysis
5.3.4 Europe 2016 Commercializing Biomarkers Market Share Analysis
5.4 Southeast Asia Commercializing Biomarkers Market Analysis
5.4.1 Southeast Asia Commercializing Biomarkers Market Overview
5.4.2 Southeast Asia 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Commercializing Biomarkers Sales Price Analysis
5.4.4 Southeast Asia 2016 Commercializing Biomarkers Market Share Analysis
5.5 Japan Commercializing Biomarkers Market Analysis
5.5.1 Japan Commercializing Biomarkers Market Overview
5.5.2 Japan 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Commercializing Biomarkers Sales Price Analysis
5.5.4 Japan 2016 Commercializing Biomarkers Market Share Analysis
5.6 India Commercializing Biomarkers Market Analysis
5.6.1 India Commercializing Biomarkers Market Overview
5.6.2 India 2012-2017E Commercializing Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Commercializing Biomarkers Sales Price Analysis
5.6.4 India 2016 Commercializing Biomarkers Market Share Analysis

6 Global 2012-2017E Commercializing Biomarkers Segment Market Analysis (by Type)
6.1 Global 2012-2017E Commercializing Biomarkers Sales by Type
6.2 Different Types of Commercializing Biomarkers Product Interview Price Analysis
6.3 Different Types of Commercializing Biomarkers Product Driving Factors Analysis
6.3.1 Consumables of Commercializing Biomarkers Growth Driving Factor Analysis
6.3.2 Services of Commercializing Biomarkers Growth Driving Factor Analysis
6.3.3 Software of Commercializing Biomarkers Growth Driving Factor Analysis

7 Global 2012-2017E Commercializing Biomarkers Segment Market Analysis (by Application)
7.1 Global 2012-2017E Commercializing Biomarkers Consumption by Application
7.2 Different Application of Commercializing Biomarkers Product Interview Price Analysis
7.3 Different Application of Commercializing Biomarkers Product Driving Factors Analysis
7.3.1 Oncology of Commercializing Biomarkers Growth Driving Factor Analysis
7.3.2 Cardiology of Commercializing Biomarkers Growth Driving Factor Analysis
7.3.3 Neurology of Commercializing Biomarkers Growth Driving Factor Analysis
7.3.4 Others of Commercializing Biomarkers Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Commercializing Biomarkers
8.1 Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Roche 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Roche 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.2 Dako (Agilent Technologies)
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Dako (Agilent Technologies) 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Dako (Agilent Technologies) 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.3 Merck
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Merck 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Merck 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.4 BD
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 BD 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 BD 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.5 Abbott
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Abbott 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Abbott 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.6 Genesys Biolabs (20/20GeneSystems)
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Genesys Biolabs (20/20GeneSystems) 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Genesys Biolabs (20/20GeneSystems) 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.7 Affymetrix
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Affymetrix 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Affymetrix 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.8 Agendia
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Agendia 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Agendia 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.9 ALMAC
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 ALMAC 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 ALMAC 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.10 Arrayit
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Arrayit 2016 Commercializing Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Arrayit 2016 Commercializing Biomarkers Business Region Distribution Analysis
8.11 Biocartic
8.12 BG Medicine
8.13 KEGG EXPRESSION Database
8.14 Thermo Fisher
8.15 BGI

9 Development Trend of Analysis of Commercializing Biomarkers Market
9.1 Global Commercializing Biomarkers Market Trend Analysis
9.1.1 Global 2017-2022 Commercializing Biomarkers Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Commercializing Biomarkers Sales Price Forecast
9.2 Commercializing Biomarkers Regional Market Trend
9.2.1 North America 2017-2022 Commercializing Biomarkers Consumption Forecast
9.2.2 China 2017-2022 Commercializing Biomarkers Consumption Forecast
9.2.3 Europe 2017-2022 Commercializing Biomarkers Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Commercializing Biomarkers Consumption Forecast
9.2.5 Japan 2017-2022 Commercializing Biomarkers Consumption Forecast
9.2.6 India 2017-2022 Commercializing Biomarkers Consumption Forecast
9.3 Commercializing Biomarkers Market Trend (Product Type)
9.4 Commercializing Biomarkers Market Trend (Application)

10 Commercializing Biomarkers Marketing Type Analysis
10.1 Commercializing Biomarkers Regional Marketing Type Analysis
10.2 Commercializing Biomarkers International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Commercializing Biomarkers by Region
10.4 Commercializing Biomarkers Supply Chain Analysis

11 Consumers Analysis of Commercializing Biomarkers
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis


12 Conclusion of the Global Commercializing Biomarkers Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source